期刊文献+

乙基纤维素在缓控释制剂中的应用进展 被引量:9

原文传递
导出
摘要 乙基纤维素(EC)是纤维素链中的部分羟基被乙氧基取代的纤维素衍生物,是应用最广泛的水不溶性纤维素衍生物之一,在药剂中有多种用途,如:可用作片剂黏合剂、薄膜包衣材料,亦可用作骨架材料制备多种类型的骨架型缓释片,用作混合材料膜制备包衣缓释制剂,用作包囊辅料制备缓释微囊,还可作为载体材料广泛地用于制备固体分散体等。近年来,人们对EC缓释片进行了较深入的研究,选择茶碱、布洛芬、吲哚美辛为模型药物制备的制剂获得了令人满意的缓控释效果。
作者 于立军
出处 《中国药房》 CAS CSCD 北大核心 2010年第29期2776-2777,共2页 China Pharmacy
  • 相关文献

参考文献14

  • 1Riikka MK, Eero S, Ossi K,et al. Controlled release of saccharides from matrix tablets[J]. European Journal of Pharmaceutics and Biopharmaceutics, 2006,62 (2) : 163.
  • 2Shi P J, Zuo Y, Zou Q, et al. Improved properties of incorporated chitosan film with ethyl cellulose microspheres for controlled release[J]. International Journal of Pharmaceutics, 2009,375(1-2) : 67.
  • 3Tan J J, Li YX, Liu RG, et al. Micellization and sustained drug release behavior of EC-g-PPEGMA amphiphilic copolymers [J]. Carbohydrate Polymers, 2010, 81 (2) : 213.
  • 4Parthasarathy V, Manavalan R, Mythili R, et al. Ethyl cellulose and polyethylene glycol-based sustained-release sparfloxacin chip: an alternative therapy for advanced periodontitis[J]. Drug Development and Industrial Pharmacy, 2002,28 (7) : 849.
  • 5Bromberg LE, Buxton DK, Friden PM. Novel periodontal drug delivery system for treatment of periodontitis[J]. Journal of Controlled Release, 2001,71 ( 3 ) : 251.
  • 6Morales ME, Lara VG, Calpena AC, et al. Comparative study of morphine diffusion from sustained release poly- meric suspensions[J]. Journal of Controlled Release, 2004,95(1) :75.
  • 7邢国胜,王巨存.双氯芬酸钠-乙基纤维素固体分散物释放动力学研究[J].天津药学,2001,13(4):31-33. 被引量:6
  • 8李晓芳,洪慧,何琳.阿司匹林胃漂浮微球的制备[J].广东药学院学报,2006,22(1):13-15. 被引量:10
  • 9张岩,陈岚,李保国,华泽钊,伍贻文,刘哲鹏,陆伟跃.超临界CO_2抗溶剂法制备乙基纤维素微球试验[J].化学工程,2005,33(3):63-67. 被引量:9
  • 10Randolph F, Anomedicine and drug delivery symposium [J]. Nanomedicine: Nanotechnology, Biology and Medicine, 2006,2(1) : 49.

二级参考文献28

  • 1孙桂明,裴元英.乙基纤维素作为硫酸奎尼丁缓释型固体分散体载体的研究[J].上海医科大学学报,1995,22(6):459-461. 被引量:4
  • 2郑玲妹,金昭英.萘普生缓释片的研制[J].上海医科大学学报,1995,22(6):457-458. 被引量:2
  • 3张志荣,王丹,廖方义,廖工铁.肝动脉栓塞米托蒽醌乙基纤维素微球的研究[J].药学学报,1996,31(8):626-631. 被引量:15
  • 4Hannay J B, Hogarth J. On the solubility of solids in gases [J]. Proc Roy London, 1879,29(3):324-331.
  • 5Krukonis V J. Supercritical fluid nucleation of difficult-tocomminute solids [A]. AIChE Annual Meeting [C].USA:San Francisco Press, 1984.1245-1256.
  • 6Knakonis V J, Coffey M P, Gallagher P M. Exploratory development on a net process to produce improved RDX crystal: Supercritical fluid antisolvent recrystallization[R]. Maryland: Phasex Corporation Final Report to US Army Ballistics Research Laboratory, 1988.
  • 7Reverehon E, Della Porta G, Falivenee M G. Process parameters and morphology in amoxicillin micro and submicro particles generation by supercritical antisolvent preci-pitation [J]. The Journal of Supercritical Fluids, 2000,17: 239-248.
  • 8Reverchon E, De Marco I, Della Porta G. Tailoring of nano- and micro-particles of some superconductor precursors by SAS precipitation [J]. The Journal of Supercritical Fluids ,2002,23:81-87.
  • 9Taki S, Badens E, Charbit G. Controlled release system formed by supercritical antisolvent coprecipitation of a herbicide and a biodegradable polymer [J]. The Journal of Supercritical Fluids,2001,21:61-70.
  • 10Yeo S D, Lim G B, Debenedetti P G,et al. Formation of microparticulate protein powders using a supercritical fluid antisolvent [J]. Biotech Bioengng, 1993,41:341-346.

共引文献22

同被引文献84

引证文献9

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部